Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Reading functions in patients with maculopathy after cataract extraction with WIOL-CF polyfocal bioanalogic lens implantation: one year results comparison with non-maculopathy patients

Poster Details

First Author: M.Alexik SLOVAKIA

Co Author(s):                        

Abstract Details

Purpose:

To compare the actual amount of benefit of WIOL-CF polyfocal bioanalogic lens implantation on reading functions relatively to impaired distance vision in patients with maculopathy

Setting:

Retrospective analysis of nonrandomized single case series, each patient operated by single surgeon (author) at O�Ä�n�Ã�© oddelenie, Fakultn�Ã�¡ nemocnica s poliklinikou �Å�½ilina, Slovakia

Methods:

24 healthy cataract surgery patients (30 eyes) and 15 patients with cataract and mild maculopathy (20 eyes) were assigned to have bilateral implantation of WIOL-CF polyfocal bioanalogic lens (MEDICEM Technology s.r.o., Czech Republic) in the capsular bag. The main study outcomes were assessed at 6 month follow-up visit and included uncorrected distance, intermediate (70cm) and near (40cm) visual acuity. To assess the amount of surgery benefit on reading functions relatively to postoperative distance vision, we compared the inclination of linear regression curves from the data of both groups

Results:

The difference between maculopathy and healthy group was statistically significant for UCIVA (p=0,02) and UCNVA (p=0,002), but was not significant for UCDVA (p=0,47). Thus, the benefit of surgery regarding UCNVA relatively to distance VA is better for non-maculopathy patients.

Conclusions:

Cataract extraction with binocular WIOL-CF polyfocal bioanalogic lens implantation in patients with maculopathy provides spectacle free vision at all distances but this benefit seems to deteriorate as the distance gets distance.

Financial Disclosure:

travel has been funded, fully or partially, by a competing company

Back to Poster listing